Filing Flows › CV Sciences (CVSI) › Q1 2026 › vs Q1 2025
CV Sciences (CVSI) Q1 2026 vs Q1 2025 (year over year)
CV Sciences's revenue fell $411K (-11%) from $3.6M in Q1 2025 to $3.2M in Q1 2026.
CV Sciences, Q1 2026: revenue $3.2M (-11% year over year), operating margin -10.0%, net loss $643K, operating cash flow $101K. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.1% | -3.4% | +6.4 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3.2M | $3.6M | −$411K | -11% |
| Net loss | $643K | $109K | $534K | +490% |
| Costs & expenses | $3.8M | $3.7M | $123K | +3% |
| Operating costs | $3.5M | $3.6M | −$82K | -2% |
| Interest & other, net | $325K | $113K | $212K | +188% |
| Cost of revenue | $1.6M | $1.9M | −$315K | -16% |
| Operating cash sources | $744K | $28K | $716K | 27× |
| Depreciation & amortization | $23K | $82K | −$59K | -72% |
| Share-based compensation | $148K | $118K | $30K | +25% |
| Working capital & other | $573K | −$172K | $745K | — |
| Net loss absorbed | $643K | $109K | $534K | +490% |
| Operating cash flow | $101K | −$81K | $182K | — |
| Free cash flow (OCF − capex) | $98K | −$121K | $219K | — |
| Capital expenditures | $3K | $40K | −$37K | -92% |
Questions
How much did CV Sciences's revenue grow year over year in Q1 2026?
CV Sciences's revenue fell $411K (-11%) from $3.6M in Q1 2025 to $3.2M in Q1 2026.